4//SEC Filing
Strum Jay 4
Accession 0001562180-19-000094
CIK 0001560241other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:46 PM ET
Size
19.5 KB
Accession
0001562180-19-000094
Insider Transaction Report
Form 4
Strum Jay
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2019-01-02−13,333→ 0 totalExercise: $0.39Exp: 2024-01-21→ Common Stock (13,333 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-01-02−27,000→ 0 totalExercise: $0.39Exp: 2024-07-11→ Common Stock (27,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-01-02−15,816→ 0 totalExercise: $0.30Exp: 2022-11-09→ Common Stock (15,816 underlying) - Exercise/Conversion
Common Stock
2019-01-02$0.30/sh+39,485$11,846→ 88,904 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-01-02−10,336→ 0 totalExercise: $0.30Exp: 2023-01-09→ Common Stock (10,336 underlying) - Exercise/Conversion
Common Stock
2019-01-02$0.39/sh+40,333$15,730→ 129,237 total - Award
Stock Option (Right to Buy)
2019-01-02+15,000→ 15,000 totalExercise: $19.56Exp: 2029-01-02→ Common Stock (15,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-01-02−13,333→ 0 totalExercise: $0.30Exp: 2023-04-16→ Common Stock (13,333 underlying)
Footnotes (2)
- [F1]The shares underlying this option vest as to 25% of the shares on January 02, 2020, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]All shares underlying this option have vested.
Documents
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001706851
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 5:46 PM ET
- Size
- 19.5 KB